Global Pharmacovigilance Market Is Expected To Reach $21.4 Billion By 2031

According to a new market research report published by sheer analytics and insights, “The Global Pharmacovigilance Market was $6.9 Bn in 2020, and it is expected to reach $21.4 Bn by 2031. It is eventually growing at a commendable high compound annual growth rate CAGR of 10.1% between 2021-2031”, as per the latest market research report titled, Global Pharmacovigilance Market- Industry analysis, size, share, growth, trends and forecast, 2021 – 2031.

Get Sample Copy With Covid19 Impact Analysis:

Increased cases of chronic diseases like diabetes, oncological diseases, cardiovascular and respiratory disorders have led to the consumption of the drug across the world. Also the increased incidences of Adverse Drug Reactions ADRs) will help to accelerate the growth of this market during the forecasted period. also, the demand for the development of new drugs via extensive clinical trials has increased. But because of the current COVID-19 pandemic, there has been an adverse effect on the market.

Geographically, The Global Pharmacovigilance Market is divided into global regions like North America, Europe, Asia- Pacific, Latin America, Middle East, and Africa.  

The primary key players in the Global Pharmacovigilance Market include Accenture, Linical Accelovance, Cognizant, Laboratory Corporation of America Holdings, IBM Corporation, ArisGlobal, ICON plc., Capgemini, ITClinical, FMD K&L, IQVIA, TAKE Solutions Ltd., PAREXEL International Corporation, BioClinica Inc., Wipro Ltd., United BioSource Corporation.

Browse The Full Reports at

The Global Pharmacovigilance Market Has Been Segmented Into:

Global Pharmacovigilance MarketBy Service Provider

  • In-house
  • Contract Outsourcing

Global Pharmacovigilance MarketBy Product Life Cycle

  • Pre-clinical
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Global Pharmacovigilance MarketBy Type

  • Spontaneous Reporting
  • Intensified ADR Reporting
  • Targeted Spontaneous Reporting
  • Cohort Event Monitoring
  • EHR Mining

Global Pharmacovigilance MarketBy Process Flow

  • Case Data Management
    • Case Logging
    • Case Data Analysis
    • Medical Reviewing & Reporting
  • Signal Detection
    • Adverse Event Logging
    • Adverse Event Analysis
    • Adverse Event Review & Reporting
  • Risk Management System
    • Risk Evaluation System
    • Risk Mitigation System

Global Pharmacovigilance MarketBy Therapeutic Area

  • Oncology
  • Neurology
  • Cardiology
  • Respiratory Systems
  • Others

Global Pharmacovigilance MarketBy End-Use

  • Pharmaceuticals
  • Biotechnology Companies
  • Medical Device Manufacturers
  • Others

Global Pharmacovigilance MarketBy Region

  • North America
    • USA
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America, Middle East & Africa
    • Brazil
    • South Africa
    • UAE
    • Rest of LAMEA

Download Free PDF Sample Request:

About Us:

Sheer Analytics and Insights as the firm is created to balance client requirements without compromising the core values of Market research in –terms of quality, factual correctness, market awareness, and analysis. SAI goes back to the root of Market Research in terms of TAM (Total Available Market) and PAM (Potential Available Market) and assess the same quantifying all Push and Pull factors.

Contact us:

Name: Abhigyan Sengupta

(Global Sales Manager)

Ph.: +1-414-240-5010 (U.S.)



Leave a Reply

Your email address will not be published. Required fields are marked *